These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22917059

  • 1. 5-HT2 ligands in the treatment of anxiety and depression.
    Quesseveur G, Nguyen HT, Gardier AM, Guiard BP.
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1701-25. PubMed ID: 22917059
    [Abstract] [Full Text] [Related]

  • 2. Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).
    Yang Y, An S, Liu Y, Guo XX, Gao L, Wei JF, Xu TR.
    Expert Opin Ther Pat; 2016 Nov; 26(1):89-106. PubMed ID: 26609882
    [Abstract] [Full Text] [Related]

  • 3. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M, David DJ, Jolliet P, Gardier A.
    Therapie; 2002 Nov; 57(4):385-96. PubMed ID: 12422559
    [Abstract] [Full Text] [Related]

  • 4. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 5. Potential role of cortical 5-HT(2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal.
    Benyamina A, Naassila M, Bourin M.
    Psychiatry Res; 2012 Jul 30; 198(2):307-12. PubMed ID: 22421069
    [Abstract] [Full Text] [Related]

  • 6. [Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
    Fedotova IuO, Ordian NE, Frolova HO, Soboliev VI.
    Fiziol Zh (1994); 2012 Jul 30; 58(6):75-80. PubMed ID: 23530416
    [Abstract] [Full Text] [Related]

  • 7. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM.
    J Clin Psychiatry; 1997 Jul 30; 58 Suppl 8():20-6. PubMed ID: 9236732
    [Abstract] [Full Text] [Related]

  • 8. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I.
    J Clin Psychiatry; 1991 Dec 30; 52 Suppl():24-31. PubMed ID: 1684363
    [Abstract] [Full Text] [Related]

  • 9. Identification of 5-HT(2C) mediated mechanisms involved in urethral sphincter reflexes in a guinea-pig model of urethral function.
    Conlon K, Miner W, McCleary S, McMurray G.
    BJU Int; 2012 Jul 30; 110(2 Pt 2):E113-7. PubMed ID: 22192599
    [Abstract] [Full Text] [Related]

  • 10. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I, Bambico FR, Mechawar N, Nobrega JN.
    Neurosci Biobehav Rev; 2014 Jan 30; 38():173-92. PubMed ID: 24300695
    [Abstract] [Full Text] [Related]

  • 11. Serotonin receptors involved in antidepressant effects.
    Artigas F.
    Pharmacol Ther; 2013 Jan 30; 137(1):119-31. PubMed ID: 23022360
    [Abstract] [Full Text] [Related]

  • 12. Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.
    Mendez-David I, David DJ, Darcet F, Wu MV, Kerdine-Römer S, Gardier AM, Hen R.
    Neuropsychopharmacology; 2014 May 30; 39(6):1366-78. PubMed ID: 24287720
    [Abstract] [Full Text] [Related]

  • 13. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
    Rainer Q, Xia L, Guilloux JP, Gabriel C, Mocaër E, Hen R, Enhamre E, Gardier AM, David DJ.
    Int J Neuropsychopharmacol; 2012 Apr 30; 15(3):321-35. PubMed ID: 21473810
    [Abstract] [Full Text] [Related]

  • 14. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.
    Millan MJ.
    Therapie; 2005 Apr 30; 60(5):441-60. PubMed ID: 16433010
    [Abstract] [Full Text] [Related]

  • 15. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
    Zaniewska M, McCreary AC, Wydra K, Filip M.
    Neuropharmacology; 2010 Jun 30; 58(7):1140-6. PubMed ID: 20153341
    [Abstract] [Full Text] [Related]

  • 16. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Jun 30; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 17. "Selectivity": an attractive but often misleading notion.
    Prescrire Int; 2014 May 30; 23(149):120. PubMed ID: 24926509
    [No Abstract] [Full Text] [Related]

  • 18. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?
    Tanti A, Belzung C.
    Neuroscience; 2013 Nov 12; 252():234-52. PubMed ID: 23973415
    [Abstract] [Full Text] [Related]

  • 19. Neuropeptides: relevance in treatment of depression and anxiety disorders.
    Madaan V, Wilson DR.
    Drug News Perspect; 2009 Nov 12; 22(6):319-24. PubMed ID: 19771321
    [Abstract] [Full Text] [Related]

  • 20. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S.
    Psychopharmacol Bull; 1994 Nov 12; 30(1):39-43. PubMed ID: 7972628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.